The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read More(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read More(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation Published: Jul
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS has approved a proposal from California to eliminate asset tests for Medicaid
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollees who use supplemental benefits are more likely to live in
Read More(By Rylee Wilson for Becker’s Hospital Review) Virginia made capitation payments for thousands of Medicaid enrollees after their deaths, an
Read More(By Rylee Wilson for Becker’s Hospital Review) HHS’ Office of Inspector General raised concerns about the rate of prior authorization
Read More(Contact Craig Palosky for the Kaiser Family Foundation published June 15, 2023) Most (58%) people with health insurance say they
Read More(By Rylee Wilson for Becker’s Hospital Review) New GLP-1 drugs to treat diabetes and obesity can be expensive, and most
Read More(By Riz Hatton for Becker’s Hospital Review) Sixty-five percent of physicians plan to continue treating Medicare and Medicaid patients, according
Read More(By Rylee Wilson for Becker’s Hospital Review) More people will be uninsured in 2033 than in 2023 as Medicaid continuous
Read More